Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

ISSN： 0012-6667

Source： Drugs, Vol.63, Iss.3, 2003-01, pp. : 275-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy

By Léger Jean-Marc

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. : 569-582

Informa Healthcare

Access to resources Recommend Favorite

Newer Therapeutic Options for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

By Kuitwaard Krista van Doorn Pieter A.

Drugs, Vol. 69, Iss. 8, 2009-06 ,pp. : 987-1001

Adis International

Access to resources Recommend Favorite

Oxaliplatin: Acute inflammatory demyelinating polyradiculoneuropathy: case report

Reactions Weekly, Vol. 1, Iss. 1409, 2012-01 ,pp. : 35-35

Adis International

Access to resources Recommend Favorite

Chronic Inflammatory Demyelinating Polyneuropathy Possibly Associated with Tacrolimus

By Haviv Y.S. Friedlaender M. Dranitzki-Elhallel M.

Clinical Drug Investigation, Vol. 18, Iss. 2, 1999-08 ,pp. : 169-172

Adis International

Access to resources Recommend Favorite

Peginterferon alfa 2b: Chronic inflammatory demyelinating polyneuropathy: case report

Reactions Weekly, Vol. 1, Iss. 1304, 2010-01 ,pp. : 29-29

Adis International

Access to resources Recommend Favorite